The Conversation (0)
MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.
MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.
As quoted in the market news:
MicroDose Therapeutx will receive additional payments of up to USD125m upon achievement of regulatory and development milestones, plus sales-based milestones and tiered royalty payments upon commercialisation of MDT-637 and an earlier stage Asthma/COPD medicine.
A drug delivery company, MicroDose Therapeutx is focused on inhalation technologies and products for lung diseases and infections with the potential to dramatically improve efficacy and patient compliance.